It’s time to retire the ME Diagnosis
The push for ever-narrower definitions rests on a seductive logic: identify the ‘true’ ME patient, and research will…
RFK Jr. draws backlash for ripping Medicaid programs that pay people to care for relatives
Health and Human Services Secretary Robert F. Kennedy Jr. sparked outrage among disability rights advocates with recent comments…
How the CanAssist Breast Test Is Helping Doctors Decide Whether Breast Cancer Patients Need Chemotherapy
The Oncotype DX test analyses a breast cancer tumour sample to predict the likelihood of cancer recurrence. The…
Discount telehealth visits raise concerns about pharma company ties
The little pink pill recently got a retail boost. Addyi, a drug that treats low libido in premenopausal…
RFK Jr agenda suffers another loss as trans advocates hail ‘huge step forward’ | US healthcare
A federal judge overturned the Trump administration’s ban on gender-affirming care for children on Saturday, decrying Robert F…
Using AI To Personalize Healthcare–Without Losing Patient Trust
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize…
Drap orders countrywide crackdown on unsafe syringes amid HIV surge
A health worker fills a disposable injection with a medicine.— AFP/FileProvinces ordered market survey, enforcement.Unsafe injections linked to…
WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming…
The Asian healthcare gold rush: Vietnam’s reforms are attracting foreign investors
The changing landscape is fuelled by rapid urbanisation, income growth and an expanding middle class [SINGAPORE] EVEN as…
A free shower is the least older people can expect. But aged care funding misses one key point
This week, we learned older people in home-based aged care will no longer have to pay out-of-pocket for…
ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
In ACHIEVE-4, Foundayo met the primary objective of non-inferiority vs. insulin glargine with a 16% lower risk of…
2 Healthcare Stocks at 52-Week Lows That Analysts Still Love
Both Abbott Laboratories (ABT) and Boston Scientific (BSX) trade at or near 52-week lows while Wall Street analysts…